Should reflect in Q1
Posts in category All News
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk? (06-07-2024)
Rahul Gandhi to be on Gujarat visit; to address party workers and meet Rajkot fire victims’ kin (06-07-2024)
India Ratings’ Devendra Pant on how water shortage can impact economic growth (06-07-2024)
Natco Pharma: Focusing On Complex Products (06-07-2024)
The ratings reaffirmation from ICRA considers Natco Pharma Limited’s healthy abbreviated new drug application (ANDA) portfolio in the complex generics space in the US market.
Based on the report, the positive aspects of Natco Pharma Limited are:
-
Healthy ANDA portfolio in complex generics space
-
Strong R&D capabilities
-
Notable market position in domestic oncology segment
-
Robust financial profile with low debt and strong liquidity
-
Strong manufacturing capabilities and backward integration into API manufacturing
-
Diversification into agrochemical segment
-
Substantial revenue contribution from gRevlimid and gCopaxone
-
Improvement in operating profit margins (OPM)
-
Strong cash and cash equivalents position
-
Negative net-debt position
And the negative aspects are:
-
High product concentration risk
-
High working capital intensity
-
Increasing competition in key markets
-
Exposure to regulatory risks and litigations
-
Warning letter from US FDA for Kothur facility
-
Dependence on few critical molecules
-
High inventory days
-
Increasing scrutiny by US FDA
-
Compliance costs and risks associated with regulatory requirements
-
Potential adverse outcomes on product litigations.
Personal Investment Disclosure: Invested. My comments are my personal opinions and may not reflect the company’s current situation.
Which pockets will see profits decelerate, remain flattish, or go up in Q1? Pankaj Tibrewal answers (06-07-2024)
Marksans Pharma- Can it be the next Pharma Biggie? (06-07-2024)
Which quarter should show Teva unit revenue numbers contribution any idea ? Also anywhere we can check their USFDA observations response status ?
Smallcap momentum portfolio (06-07-2024)
Typically many of these funds hold a large number of stocks and their rebalance frequency is also distant. For small cap and micro cap, we are rebalancing every week and therefore, I expect that we are more nimble. As we have limited number of stocks, I think we will be holding the stronger stocks, going up or down.
I had a brief look at the fund on valueresearch.
In addition to equity, they hold some debt also. Further, not clear what their universe is. Many of their top holdings like Reliance or Park Hotels, or United Spirits will not appear in any momentum screening. Therefore, they must be using a discretionary element also.
At the end of the day, it depends on what you want and how much time you have to spare.
It will give me greater pleasure in a pf that I have designed than investing in a MF, even if the returns are the same.